• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

Recent Advances in the Application of Naphthalene-2-sulfonohydrazide (CAS: 10151-46-9) in Chemical Biology and Pharmaceutical Research

Naphthalene-2-sulfonohydrazide (CAS: 10151-46-9) is a chemical compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This sulfonohydrazide derivative is known for its unique chemical properties, including its ability to act as a precursor in the synthesis of various biologically active molecules. Recent studies have explored its potential in drug discovery, particularly in the development of enzyme inhibitors and antimicrobial agents. This research brief aims to provide an overview of the latest advancements related to Naphthalene-2-sulfonohydrazide, focusing on its synthesis, mechanistic insights, and therapeutic applications.

One of the key areas of research involving Naphthalene-2-sulfonohydrazide is its role in the synthesis of sulfonamide-based drugs. Sulfonamides are a well-known class of compounds with broad-spectrum antibacterial activity. Recent publications have highlighted the use of Naphthalene-2-sulfonohydrazide as a building block for the development of novel sulfonamide derivatives with enhanced efficacy against resistant bacterial strains. For instance, a 2023 study demonstrated that derivatives of Naphthalene-2-sulfonohydrazide exhibited potent inhibitory activity against Escherichia coli and Staphylococcus aureus, with minimal cytotoxicity to human cells. These findings underscore the compound's potential in addressing the global challenge of antibiotic resistance.

In addition to its antimicrobial properties, Naphthalene-2-sulfonohydrazide has been investigated for its application in cancer research. A recent study published in the Journal of Medicinal Chemistry reported the synthesis of Naphthalene-2-sulfonohydrazide derivatives that selectively target carbonic anhydrase IX, an enzyme overexpressed in many solid tumors. The study revealed that these derivatives exhibited significant antitumor activity in vitro and in vivo, suggesting their potential as lead compounds for the development of targeted cancer therapies. The mechanistic studies further elucidated the binding interactions between the sulfonohydrazide moiety and the enzyme's active site, providing valuable insights for structure-activity relationship (SAR) optimization.

Another emerging application of Naphthalene-2-sulfonohydrazide is in the field of chemical biology, where it is used as a probe to study protein-ligand interactions. Researchers have leveraged its sulfonohydrazide group to develop photoaffinity labeling agents, enabling the identification and characterization of protein targets in complex biological systems. A 2022 study utilized Naphthalene-2-sulfonohydrazide-based probes to map the interactome of a poorly characterized kinase, shedding light on its role in cellular signaling pathways. This approach has opened new avenues for target identification and validation in drug discovery.

Despite these promising developments, challenges remain in the optimization of Naphthalene-2-sulfonohydrazide derivatives for clinical use. Issues such as solubility, bioavailability, and off-target effects need to be addressed through further structural modifications and formulation studies. Recent advances in computational chemistry and high-throughput screening have facilitated the design of more potent and selective derivatives, as evidenced by a 2023 patent application describing a series of Naphthalene-2-sulfonohydrazide analogs with improved pharmacokinetic properties. These innovations highlight the ongoing efforts to translate laboratory findings into therapeutic candidates.

In conclusion, Naphthalene-2-sulfonohydrazide (CAS: 10151-46-9) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from antimicrobial agents to cancer therapeutics and chemical probes, demonstrate its versatility and potential for future drug development. Ongoing research efforts are expected to further elucidate its mechanistic underpinnings and expand its utility in addressing unmet medical needs. For researchers in the field, staying abreast of these advancements will be crucial for leveraging the full potential of this compound in their work.

• 78335-51-0(1-Pyrenesulfonic acid,hydrazide)
• 83863-50-7(2,6-Naphthalenedisulfonicacid, 2,6-dihydrazide)
• 80-17-1(Benzenesulfonyl Hydrazide)
• 1576-35-8(4-methylbenzene-1-sulfonohydrazide)
• 65227-54-5(1-Naphthalenesulfonicacid, hydrazide)
• 5450-86-2(Benzenesulfonicacid, 4-amino-, hydrazide)
• 38448-43-0(Benzenesulfonic acid,4-methyl-, hydrazide, sodium salt (1:1))
• 109333-73-5(p-Toluenesulfonylhydrazide-N,N,N-d3)
• 12448-24-7(Dodecaborate(2-)-10B12,1,2,3,4,5,6,7,8,9,10,11-undecahydro-12-mercapto-, sodium (1:2))
• 90141-56-3(Benzenesulfonic acid, 2-(methylsulfonyl)hydrazide)